Harry Björkbacka
21 – 30 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke : Meta-Analysis of Population-Based Studies Involving 17 180 Individuals
(
- Contribution to journal › Article
-
Mark
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice
(
- Contribution to journal › Article
-
Mark
Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques
(
- Contribution to journal › Article
-
Mark
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
(
- Contribution to journal › Article
- 2018
-
Mark
Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells
(
- Contribution to journal › Article
-
Mark
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(
- Contribution to journal › Article
-
Mark
IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation
(
- Contribution to journal › Article
-
Mark
Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques
(
- Contribution to journal › Article
-
Mark
Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes : The SUMMIT VIP Study
(
- Contribution to journal › Article
-
Mark
Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice
(
- Contribution to journal › Article